AAHRPP Awards Accreditation to Organizations in US, China, and Republic of Korea
The Association for the Accreditation of Human Research Protection Programs today announced that it has awarded accreditation to five more organizations
The Association for the Accreditation of Human Research Protection Programs today announced that it has awarded accreditation to five more organizations, including institutions in Seoul, Republic of Korea; Nanjing, China; Michigan; New York and Louisiana. The newly accredited organizations are:
- Asan Medical Center, Seoul, Republic of Korea
- First Affiliated Hospital of Nanjing Medical University (Jiangsu Province Hospital), Nanjing, China
- McLaren Health Care Corporation, Flint, Mich.
- North Shore-LIJ Health System, Manhasset, N.Y.
- Pennington Biomedical Research Center, Louisiana State University System, Baton Rouge, La.
“These latest accreditations demonstrate the increasing recognition that AAHRPP accreditation is the mark of excellence for human research protection programs, here and around the globe,” said Elyse Summers, AAHRPP president and CEO. “AAHRPP accreditation signifies an organization’s commitment to the highest level of research protections—all to the benefit of the research participants we are pledged to protect.”
AAHRPP accreditation is available to U.S. and international organizations that conduct biomedical, behavioral or social sciences research involving human participants. Accreditation decisions are made quarterly. They continue at a steady pace, reflecting strong interest in every sector of the research enterprise, in the U.S. and abroad.
To date, AAHRPP has accredited organizations in 46 states, Canada, China, India, Mexico, Republic of Korea, Singapore and Taiwan. All major U.S. independent institutional review boards have earned AAHRPP accreditation. In addition, more than 60 percent of U.S. research-intensive universities and 65 percent of U.S. medical schools are either AAHRPP accredited or have begun the accreditation process.
Empowering Sites and Patients: The Impact of Personalized Support in Clinical Trials
November 26th 2024To meet the growing demands of clinical research, sponsors must prioritize comprehensive support models, such as clinical site ambassadors and patient journey coordinators, who can address operational challenges and improve site relationships, patient satisfaction, and overall trial efficiency.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
FDA Finalizes Decentralized Clinical Trial Guidance
November 25th 2024The FDA's guidance is part of a broader effort to modernize clinical trials, improve efficiency, reduce participant burden, and expand access, particularly for underrepresented populations and those in geographically or economically constrained areas.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
